A Treat-to-Target Strategy with Methotrexate and Intra-Articular Triamcinolone With or Without Adalimumab Effectively Reduces MRI Synovitis, Osteitis and Tenosynovitis and Halts Structural Damage Progression in Early Rheumatoid Arthritis: Results from the OPERA Randomised Controlled Trial
Published:
October 3, 2017
Publication:
Annals of the Rheumatic Diseases
Authors:
Axelsen, M.B., Eshed, I., Hørslev-Petersen, K., Stengaard-Pedersen, K., Hetland, M.L., Møller, J., Junker, P., Pødenphant, J., Schlemmer, A., Ellingsen, T. and Ahlquist, P.
Maecenas tempor, ex at maximus efficitur, felis sem ultrices ligula, ut hendrerit purus eros ac urna. Vestibulum ut vestibulum tortor. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Cras eu lectus quam. Nunc ligula arcu, auctor sit amet tellus eleifend, facilisis laoreet odio. Donec placerat urna eleifend blandit porttitor.
Nunc magna turpis, tristique at dictum vel, sollicitudin blandit felis. Morbi aliquam elit et pellentesque vulputate. Donec elementum, ante quis ornare porttitor, tortor dolor vestibulum velit, et viverra enim massa vitae ex.